Wrestling fans who were unfamiliar LJ Cleary were introduced to the Irish professional wrestler at WWE Backlash earlier this ...

Lyra Therapeutics's LYRA short percent of float has risen 171.37% since its last report. The company recently reported that ...

Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

Becky Lynch and Lyra Valkyria clash once again for the women's Intercontinental title at WWE Money in the Bank — this is the ...

Lyra also reported success on key secondary endpoints. These included improvements in broader symptom scores and patient ...

An insurance executive with decades of experience has found a new role at another Massachusetts-based industry leader.

Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate ...

DP Energy has partnered with ESB to develop Lyra wind farm in County Mayo, a renewable energy project with the potential to ...

Lyra Valkyria reflects on learning that she would be crowned the first-ever Women's Intercontinental Champion.

Lyra Valkyria stepped into the ring with Becky Lynch at WWE Backlash, successfully defending her WWE Intercontinental ...

Here are the five things you need to know, including Lyra's good news, Sanofi's acquisition, Mass. biotech jobs, inside Market Basket's board, AI, and hiring entry-level jobs.

WATERTOWN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company ...